Search

everythinglearnresearchcommunity

for

Search:↓

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Androgens can cause hair growth in some areas and hair loss on the scalp.

A 46-year-old man showed symptoms of a rare condition usually seen in postmenopausal women, highlighting the need for dentist-dermatologist collaboration.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

The document suggests that certain protein deficiencies and scalp blistering in Epidermolysis Bullosa may cause hair loss.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

A man with skin and hair symptoms improved partially with specific treatment.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Careful planning and accurate diagnosis are crucial for successful hair restoration surgery.

The patient was diagnosed with oral lichen sclerosus and needs long-term monitoring.

Syphilis can cause hair loss that looks like other conditions, but it improves with treatment.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

A new type of hereditary hair loss in a Chinese family is linked to chromosome 2p25.1–2p23.2.